EKF.L Stock Analysis
EK
Neutral
Based on Eyestock quantitative analysis, EKF.L`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Undervalued
Market cap $B
0.184
Dividend yield
8.30 %
Shares outstanding
454.93 B
EKF Diagnostics Holdings Plc is a vitro diagnostics company, which designs and manufactures diagnostic equipment for use within point-of-care settings. The company is headquartered in Penarth, South Glamorgan and currently employs 386 full-time employees. The company went IPO on 2002-06-05. The company sells through a network of distributors across the world. Its German and American offices also sell directly into hospital laboratories, GP surgeries, as well as into universities and sports organizations. The company has five divisions: Central Laboratory, Life Sciences, Lab Services, Contract Manufacturing and Point of Care. Central Laboratory division manufactures a spectrum of reagents for use in hospital laboratories. Life Sciences division specializes in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry. Lab Services division operates through ADL Health, which is a laboratory services company, which is engaged in lab testing and specializes in quick turnaround services. Contract Manufacturing division provides specialized services to the diagnostics and healthcare industries for the production of custom kits.